Aclarion Inc. (Nasdaq: ACON), a Broomfield-based healthcare technology company, reported a 132% year-over-year increase in scan volume for its flagship product, Nociscan, from Q2 2024 to Q2 2025. This marks the company’s first time achieving two consecutive quarters of scan growth. Nociscan uses proprietary AI algorithms and magnetic resonance spectroscopy to help physicians identify the…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here